1929.3000 -33.30 (-1.70%)
NSE Oct 08, 2025 15:31 PM
Volume: 306.7K
 

1929.30
-1.70%
HDFC Securities
Maintain buy with a TP of Rs 800 (16x Dec-21E EPS + Rs 135/sh for pipeline). Glenmark reported broadly in-line numbers as revenues grew 16% YoY to Rs 25.6bn, and EBITDA came in at Rs 4.3bn with 17% margin. However, PAT at Rs 1.2bn was much lower than expectation owing to a Rs 1.3bn forex loss included in other income.
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended